[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![CMDarnton Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1936166431378300928.png) Christian Darnton [@CMDarnton](/creator/twitter/CMDarnton) on x 6030 followers
Created: 2025-07-25 20:50:21 UTC

Still, the risk isn’t zero.

→ If regulators challenge the clinical necessity claims en masse, compounded GLP-1s could face new constraints
→ If pharma pursues IP lawsuits aggressively, the cost could be severe
→ If the FDA tightens 503A definitions, personalization may become harder to justify

Hims is not immune to these pressures.


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948848317384757686/c:line.svg)

[Post Link](https://x.com/CMDarnton/status/1948848317384757686)